Clinical Trials Logo

Pneumonia, Interstitial clinical trials

View clinical trials related to Pneumonia, Interstitial.

Filter by:
  • None
  • Page 1

NCT ID: NCT04734067 Not yet recruiting - Clinical trials for Pneumonia, Interstitial

Exploration of the Predictive Marker and Establishment of Predictive Models of Checkpoint Inhibitor Pneumonitis

Start date: August 20, 2021
Phase:
Study type: Observational

This is a prospective, multicenter observational study to explore the predictive factors of checkpoint inhibitor pneumonitis (CIP) and to establish predictive models by combining imaging information for IRP. The imaging type of CIP, the pathological type, various inflammatory cytokines and tumor proportion score(TPS) of PD-L1 expression level, etc. will be paid more attention.

NCT ID: NCT04481074 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

Inspiratory Muscle Training in Patients With Interstitial Lung Disease

IMT-ILD
Start date: July 30, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effects of inspiratory muscle training program in inspiratory muscle endurance, breathlessness, inspiratory muscle strength, functional capacity and quality of life in patients with interstitial lung disease. Patients are evaluated before the inspiratory muscle training and after 8 weeks of training.

NCT ID: NCT04382547 Completed - Covid-19 Clinical Trials

Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells

Start date: May 11, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Treatment of patients with Covid-19 associated pneumonia using intravenous injection of allogenic pooled olfactory mucosa-derived mesenchymal stem cells

NCT ID: NCT04333251 Not yet recruiting - Clinical trials for Pneumonia, Interstitial

Study Testing Convalescent Plasma vs Best Supportive Care

Start date: April 1, 2020
Phase: Phase 1
Study type: Interventional

Currently there are no proven treatment option for COVID-19. Human convalescent plasma is an option for COVID-19 treatment and could be available from people who have recovered and can donate plasma.

NCT ID: NCT04313946 Recruiting - COVID-19 Clinical Trials

Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays

AI-COVID-Xr
Start date: March 18, 2020
Phase:
Study type: Observational

This project aims to use artificial intelligence (image discrimination) algorithms, specifically convolutional neural networks (CNNs) for scanning chest radiographs in the emergency department (triage) in patients with suspected respiratory symptoms (fever, cough, myalgia) of coronavirus infection COVID 19. The objective is to create and validate a software solution that discriminates on the basis of the chest x-ray between Covid-19 pneumonitis and influenza